MedPath

Coagulation and Platelet Function during and after Adult Liver Transplantation with ROTEM

Not Applicable
Conditions
Digestive System
End-stage liver disease patients scheduled for liver transplantation
Registration Number
PACTR201803003217132
Lead Sponsor
ational liver institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

End stage liver disease scheduled for adult liver transplantation.

Exclusion Criteria

Patients on preoperative oral anticoagulant, antiplatelets.
Patients on any drugs affecting platelets function and count or causing pancytopenia e.g Impenam, Diflucan.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Platelet function behaviour
Secondary Outcome Measures
NameTimeMethod
Anti-platelet monitoring
© Copyright 2025. All Rights Reserved by MedPath